HeartMate 3是目前中国唯一具有人工脉冲 ... 中国医学科学院阜外医院已完成158例患者LVAD植入，并坚持对其进行长期随访。心内科主任卿平教授是 ...

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit ...

The use of mechanical support of the circulation with ventricular assist devices for ... Despite that nearly half of patients in the recent Heartmate II clinical trial were inotrope-dependent ...

which regulates the LVAD's function. The exit site requires meticulous, sterile dressing changes, initially 2 3 times a day, tapering to once a day after the site heals and the patient returns home.

Samsung Medical Center performs over 200 artificial heart surgeries in Korea Korea leads in artificial heart surgeries with ...

The left ventricular assist device market segment will reach $2.24bn by 2033. Abbott’s HeartMate 3 is the current market leader in the field and was approved by the FDA for less invasive ...